Sustained favorable long-term outcome in the treatment of schizophrenia: a 3-year prospective observational study
2011

Long-term outcomes in schizophrenia treatment

Sample size: 2327 publication 10 minutes Evidence: moderate

Author Information

Author(s): Cuyún Carter Gebra, Milton Denái R, Ascher-Svanum Haya, Faries Douglas E

Primary Institution: Eli Lilly and Company

Hypothesis

What baseline predictors are associated with sustained favorable long-term outcomes in patients with schizophrenia?

Conclusion

Only a small percentage of patients achieved sustained favorable long-term outcomes, indicating a need for improved treatment strategies for schizophrenia.

Supporting Evidence

  • Only 10% of patients experienced sustained favorable long-term outcomes.
  • Patients with better quality of life and more daily activities were more likely to achieve favorable outcomes.
  • The study identified 5 distinct health state clusters among patients.

Takeaway

Most people with schizophrenia don't get better over time, but some things like having a job or feeling clearer in your thoughts can help you do better.

Methodology

The study used a hierarchical cluster analysis and stepwise logistic regression on data from a large observational study.

Potential Biases

The sample included mostly outpatients, which may not represent all patients with schizophrenia.

Limitations

The study had infrequent assessments and may not have captured all relevant changes in patients' conditions.

Participant Demographics

Participants were adults 18 years and older, treated for schizophrenia, and included a diverse population.

Statistical Information

P-Value

p = .0029

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-244X-11-143

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication